Cited by 37Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsBody Composition Measurement Techniques

Lean Muscle Mass in Classic or Ovulatory PCOS: Association with Central Obesity and Insulin Resistance

Mario, F., do Amarante, F., Toscani, M., Spritzer, P.·2012·Experimental and Clinical Endocrinology & Diabetes

Abstract

This age-matched case-control study assessed total and segmental lean muscle mass in classic or ovulatory polycystic ovary syndrome (PCOS) patients and investigated whether lean mass is associated with hormone and metabolic features. Participants underwent anthropometric and clinical evaluation. Habitual physical activity was assessed with a digital pedometer, and body composition by dual-energy X-ray absorptiometry. Laboratory measurements included total cholesterol, cholesterol fractions, triglycerides, glucose, total serum testosterone, serum insulin, estradiol, luteinizing hormone, and SHBG. Energy intake was calculated using a food frequency questionnaire. Classic PCOS patients had higher body mass index (BMI), waist circumference, testosterone and lipid accumulation product values than ovulatory PCOS and controls. Energy consumption, homeostasis model assessment index, SHBG, free androgen index and triglycerides, total and trunk lean mass were higher only in classic PCOS women vs. controls. Arm, leg, trunk, total or limb lean masses were not correlated with hormone levels in any of the groups. However, in PCOS women lipid accumulation product was positively correlated with total (r=0.56, p=0.001), trunk (r=0.59, p=0.001), arm (r=0.54, p=0.001), leg (r=0.44, p=0.03) and limb (r=0.48, p=0.001) lean masses. BMI was positively correlated with all lean mass segments and independently associated with total lean mass. Lipid accumulation product and BMI were independently associated with trunk lean mass variation. The increase in lean mass in classic PCOS appears to be associated with insulin resistance and central obesity rather than with energy intake, physical activity or androgens.

Integrity signals

Registry

Crossref · 10.1055/s-0032-1309006

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ten studies included information regarding the use of wearables.

    “Ten studies included information regarding the use of wearables [77,78,79,80,81,82,83,84,85,86] (Supplementary File S3).”
  • Wearables used included activity trackers, sleep monitors, 24-h blood pressure monitors, and more invasive ones inserted into the abdominal interstitial tissue for continuous glucose monitoring.

    “Wearables used included activity trackers [78,79,82], sleep monitors [77,80], 24-h blood pressure monitors [83], and more invasive ones inserted into the abdominal interstitial tissue for continuous glucose monitoring [81,84,85,86].”
  • Publication dates of wearable studies spanned from 2009 to 2022, with three originating from China, two from Brazil, two from the USA, and one each from Croatia, Poland, and the UK.

    “Publication dates spanned from 2009 to 2022, with three of them originating from China [81,85,86], two from Brazil [78,82], two from the USA [77], and one each from Croatia [84], Poland [83], and the UK [80].”

Cited by

Sorted by citations

Authors
Mario, F., do Amarante, F., Toscani, M., & Spritzer, P.
Affiliations
  • Hospital de Clínicas de Porto Alegre (BR)
  • National Institute of Hormones and Women’s Health, CNPq, Porto Alegre, Brazil
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR)
Venue
Experimental and Clinical Endocrinology & Diabetes
Published
2012-05-10
Volume
120
Issue
09
Pages
511-516
ISSN
  • 0947-7349 (ISSN-L)
  • 1439-3646
OpenAlex
W2058040494
Cited by
37
References
0
Citations by year
2025: 3 · 2024: 6 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 8 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 3 · 2012: 1
FWCI
2.24
Type
journal article
Language
en
Open access
closed
Locations
  • Experimental and Clinical Endocrinology & Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Physiology › Body Composition Measurement Techniques
Keywords
polycystic ovary syndrome, lean muscle mass, abdominal obesity, insulin resistance, body composition, lipid accumulation product, body mass index, androgens, free androgen index, physical activity, energy intake
MeSH terms
Adolescent, Adult, Body Composition, Brazil, Female, Humans, Insulin Resistance, Ovulation, Polycystic Ovary Syndrome, Severity of Illness Index, Absorptiometry, Photon, Bone Density, Body Mass Index, Case-Control Studies, Muscle Development, Overweight, Whole Body Imaging, Waist Circumference, Young Adult, Obesity, Abdominal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review